Answers are grounded in this paper and cite their sources.
Pregabalin is effective in managing various types of neural disorders due to its ability to reduce neuronal excitability. A topical pregabalin formulation may represent a promising strategy for controlling dentin hypersensitivity pain by modulating peripheral nerve fiber responses. Objective: This randomized, double-blind, placebo-controlled clinical study aimed to evaluate the effect of an experimental gel formulation with 10% pregabalin on the control of dentin hypersensitivity (DH) and its impact on participants’ oral health-related quality of life. Methods and Materials: Sixty-four teeth (from 17 participants) were randomly assigned to the following groups: placebo gel group (Negative Control, n = 21), potassium nitrate gel group (Positive Control, n = 20) and pregabalin gel group (Pregabalin, n = 23). The impact on oral health-related quality of life was evaluated using the Dentin Hypersensitivity Experience Questionnaire (DHEQ-15) at baseline and at the final hypersensitivity recording. DH was assessed using a visual analog scale (VAS) after evaporative and tactile stimuli. Three desensitizing treatment sessions were carried out 72 hours apart, and two follow-up sessions were held at seven and 30 days after the end of treatment. The data were submitted to statistical analysis for non-parametric data. Friedman's ANOVA was followed by the Kruskal-Wallis and post hoc Dwass-Steel-Critchlow-Fligner (DSCF) pairwise comparisons. Wilcoxon and Mann-Whitney tests were used to analyze the impact on the oral health-related quality of life. All analyses adopted a 5% significance level. Results: All groups showed a significant reduction in DH ( p < 0.05), with Positive Control and Pregabalin differing statistically from Negative Control Group only by evaporative stimuli ( p < 0.05). After 30 days of treatment, all groups showed a positive impact on oral health-related quality of life ( p < 0.001). Conclusion: The 10% pregabalin gel was effective in reducing DH for 30 days and had a positive impact on the participants’ oral health-related quality of life.
No takes yet. Share an insight, caveat, or question.
Paes et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: